Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001074894 | SCV001240498 | uncertain significance | Retinal dystrophy | 2019-08-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001216794 | SCV001388606 | pathogenic | not provided | 2023-11-06 | criteria provided, single submitter | clinical testing | This sequence change replaces tryptophan, which is neutral and slightly polar, with cysteine, which is neutral and slightly polar, at codon 1618 of the ABCA4 protein (p.Trp1618Cys). This variant is present in population databases (rs61752439, gnomAD 0.009%). This missense change has been observed in individual(s) with retinal dystrophy and/or Stargardt disease (PMID: 31736247; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 812203). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Sharon lab, |
RCV001002824 | SCV001160841 | likely pathogenic | Stargardt disease | 2019-06-23 | no assertion criteria provided | research |